Syros Pharmaceuticals Inc.
SYRS
|
|
| |
|
| Trading Volume | 65,645 |
|
|
7.84 - 1.50 |
| Market Cap Full | $ 34.4M |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | 10% | -31.2% | -25.6% | -62.9% |
| Q2 | - | 13.5% | 18% | -20.4% |
| Q3 | - | -72% | 25.4% | 568.7% |
| Q4 | - | -91% | 142.7% | -44.3% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10 | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| -8.3 | 1.7 | -26.2 | -15.1 | 12.3 | 11.9 | 3.5 | -72 | - | - | - | -18.5 |
| 2023 | |||||||||||
| 42.3 | -26.4 | -29 | 19.1 | 21.1 | -18.2 | 26.4 | -2 | 1.3 | -37 | 10.4 | 183.3 |
| 2022 | |||||||||||
| -39.4 | -33.4 | -8 | -30.4 | -2.4 | 17.2 | -18.5 | 2 | 704 | -22.1 | -21.1 | -9.3 |
| 2021 | |||||||||||
| 3.5 | -23.4 | -11.2 | -18.9 | 6.8 | -15.5 | -15.2 | 14.7 | -15.1 | -8.2 | -4.1 | -17.7 |
| 2020 | |||||||||||
| -2.3 | -7.6 | -6.2 | 42.2 | 16.1 | 8.9 | -11 | 39.6 | -33.3 | -26.2 | 25 | 29.8 |
EPS
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Q1 | -0.9 | -4 | -0.2 | -0.4 |
| Q2 | -1.3 | -5.4 | -0.4 | -0.4 |
| Q3 | -1.4 | -3.2 | -0.4 | -0.4 |
| Q4 | 0 | 5.1 | -3.8 | -0.6 |
| A | -3.58 | -7.5 | -13.8 | -18.2 |